Researchers have been excited about this new drug, a groundbreaking dual agonist showing significant outcomes in early trials for weight management. It acts by targeting both pathways : GLP-1 and GIP, https://liviaxkwz529805.blogtov.com/21458110/the-new-hope-for-weight-management